🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Severe Pneumonia

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses NCT06693362Phase 11 site📍 Shanghai Ruijin Hospital · Tests: Placebo, Drug therapy, Standard Treatment Early Severe Illness TrAnslational BioLogy InformaticS in Humans NCT05591924n/a1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Phelebotomy, Broncheoalveolar Lavage, Tracheal Aspirate, Rectal Swab A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 NCT05890612n/a1 site📍 Seoul Pfizer A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised NCT07013474Phase 3159 sites📍 Canoga Park📍 Granada Hills📍 La Jolla Pfizer · Tests: ibuzatrelvir, remdesivir, placebo for ibuzatrelvir, placebo for remdesivir A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) NCT07116031Phase 235 sites📍 Los Angeles📍 Washington D.C.📍 Atlanta Sanofi · Tests: Belumosudil, Belumosudil Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951n/a50 sites📍 Hall in Tirol📍 Reutte📍 Vienna Infectopharm Arzneimittel GmbH Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) NCT05947955Phase 265 sites📍 Los Angeles📍 Augusta📍 Chicago BioAegis Therapeutics Inc. · Tests: Rhu-pGSN, normal saline A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease NCT07743580Phase 347 sites📍 Coral Gables📍 Miami📍 Miami Shionogi · Tests: Secutrelvir, Placebo Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study NCT06114784n/a15 sites📍 Hangzhou📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Metagenomics Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype NCT06269900Phase 334 sites📍 Amiens📍 Angers📍 Bordeaux Nantes University Hospital · Tests: Dexamethasone, Placebo Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies NCT06145841n/a1 site📍 Guangzhou Guangzhou 8th People's Hospital · Tests: Pathogen metagenomic next-generation sequencing Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock NCT06145828n/a1 site📍 Guangzhou Guangzhou 8th People's Hospital · Tests: Cytokine Adsorption Presynaptic Imaging in Major Depressive Episodes After COVID-19 NCT06086366n/a1 site📍 Toronto Centre for Addiction and Mental Health · Tests: [11C]DTBZ PET scan, [18F]SDM8 PET scan, MRI scan A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure NCT07615010Phase 24 sites📍 San Francisco📍 Houston📍 San Antonio MiNK Therapeutics · Tests: agenT-797, Placebo, Standard of Care (SOC) The Role of Obesity in Severe COVID-19 Pathophysiology NCT06968442NA1 site📍 Rotterdam Franciscus Gasthuis · Tests: Venipuncture Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury NCT05951777Phase 22 sites📍 Houston📍 San Antonio Hope Biosciences LLC · Tests: Autologous HB-adMSCs, Normal Saline A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease NCT06679140Phase 3256 sites📍 Huntsville📍 Little Rock📍 Bakersfield Pfizer · Tests: ibuzatrelvir, placebo Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants NCT07093580Phase 13 sites📍 Cypress📍 Lenexa📍 Salt Lake City Shionogi · Tests: S-892216-LAI, Placebo Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression NCT05688774n/a10 sites📍 Berlin📍 Berlin📍 Berlin Pneumonia Research Network on Genetic Resistance and Suscep… Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19 NCT06703034NA1 site📍 Lyon Hospices Civils de Lyon · Tests: Biological Sampling Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia NCT05903352Phase 31 site📍 Garches Assistance Publique - Hôpitaux de Paris · Tests: Stop antibiotic, Continue the antimicrobial treatment Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) NCT05722938Phase 3170 sites📍 Mobile📍 Phoenix📍 Fresno Biotest · Tests: Trimodulin, Placebo (human albumin 1%) Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen NCT05624450Phase 3471 sites📍 Birmingham📍 Mobile📍 Phoenix AstraZeneca · Tests: Tozorakimab, Placebo Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation NCT05233605n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition NCT07197138NA1 site📍 Munich Max-Planck-Institute of Psychiatry · Tests: Intermittent theta-burst stimulation (iTBS) using PowerMAG 100 ppTMS Convalescent Plasma as a Possible Treatment for COVID-19 NCT04442191Phase 21 site📍 Chicago University of Illinois at Chicago · Tests: Convalescent plasma, Placebo Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis NCT03044223n/a1 site📍 Ulm University of Ulm Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia NCT06137196n/a1 site📍 Guangzhou Guangzhou 8th People's Hospital SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study NCT04494776n/a1 site📍 São Paulo Helio Tedesco Silva Junior
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy